EP2242476A2
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
Abstract
This record has no abstract on file.
Term
Projected expiry 14 January 2029.
- Priority
- Filed
- Published
- Today
- Projected expiry
Every citation, both ways
| Reference | Relation | Cited during |
|---|---|---|
| See references of WO 2009090558A3 | Non-patent | Search report |
7 members in 5 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 20950 | United States of America | – | |
| 2095008 | United States of America | P | |
| 77779 | United States of America | – | |
| 7777908 | United States of America | P | |
| 2009005012 | International Bureau of the World Intellectual Property Organization (WIPO) | W |
Members7
| Document | Office | Kind | |
|---|---|---|---|
| AU2009205314A1 | Australia | A1 | |
| CA2712120A1 | Canada | A1 | |
| WO2009090558A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP2242476A2This record | European Patent Office (EPO) | A2 | |
| WO2009090558A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2011008266A1 | United States of America | A1 | |
| US8709385B2 | United States of America | B2 |
7 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application withdrawnWithdrawn18W | 18W | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN WITHDRAWNSTAA | STAA | |
| Deferred search report published (corrected)R17D | R17D | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 2242476
- Application
- 97019251
Titles3
- German
- AUFSCHÄUMBARE PHARMAZEUTISCHE POLOXAMER-ZUSAMMENSETZUNGEN MIT WIRKSTOFFEN UND/ODER THERAPEUTISCHEN ZELLEN UND VERWENDUNGEN
- English
- POLOXAMER FOAMABLE PHARMACEUTICAL COMPOSITIONS WITH ACTIVE AGENTS AND/OR THERAPEUTIC CELLS AND USES
- French
- COMPOSITIONS PHARMACEUTIQUES POUVANT MOUSSER DE POLOXAMÈRE AVEC DES AGENTS ACTIFS ET/OU DES CELLULES THÉRAPEUTIQUES, ET UTILISATIONS
Classification
- CPC, 17
- A61K9/122
- A61K8/046
- A61K8/90
- A61K9/06
- A61K9/107
- A61K31/19
- A61K31/196
- A61K31/506
- A61K31/522
- A61K31/60
- A61K31/7056
- A61K47/10
- A61K47/36
- A61Q19/00
- A61P17/00
- A61P29/00
- A61P31/00
- IPC, 8
- A61K9 00
- A61K8 04
- A61K8 90
- A61K9 12
- A61K31 196
- A61K31 60
- A61K47 10
- A61Q19 00
Designated states38
- Contracting states, 35
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
and 11 moreShow fewer
- North Macedonia
- Malta
- Netherlands (Kingdom of the)
- Norway
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
- Extension states, 3
- Albania
- Bosnia and Herzegovina
- Serbia